Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 12, 2012 - Issue 3
Submit an article Journal homepage
23
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Discrepancies in testing recommendations for Clostridium difficile infection: updated review favors amplification test systems

Kimberle Chapin Rhode Island Hospital & The Miriam Hospital, Department of Pathology, 593 Eddy Street, APC 11th Floor, Room 1166, Providence, RI 02903, USA and Department of Medicine, Alpert Brown Medical School, Providence, RI, USA. [email protected]
Pages 223-226 | Published online: 09 Jan 2014

References

  • Dubberke ER, Wertheimer A. Review of current literature on the economic burden of Clostridium difficile infection. Infect. Control Hosp. Epidemiol.30(1), 57–66 (2009).
  • Doing K, Hintz M. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples. Diagnostic Microbiol. Infect. Dis.72, 8–13 (2012).
  • Tenover F, Baron E, Peterson L, Persing D. Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J. Mol. Diagnostics12(6), 573–582 (2010).
  • Lyras D, O’Connor J, Howarth P et al. Toxin B is essential for virulence of Clostridium difficile. Nature458(7242), 1176–1179 (2009).
  • Voth D, Ballard J. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev.18(2), 247–263 (2005).
  • Bacci S, Molbak K, Kjeldsen MK, Olsen KEP. Binary toxin and death after Clostridium difficile infection. Emerg. Infect. Dis.17(6), 976–982 (2011).
  • Cohen S, Gerding D, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for healthcare epidemiology of America (SHEA) and the Infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol.31(5), 431–455 (2010).
  • Crobach M, Dekkers O, Wilcox M, Kuiper E. European society of clinical microbiology and infectious diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect.15(12), 1053–1066 (2009).
  • Boyanton BLJ, Sural P, Loomis C et al. Loop-mediated isothermal amplification compared to real-time pcr and enzyme immunoassay for toxigenic C. difficile detection. J. Clin. Microbiol.50(3), 640–645 (2011).
  • Chapin KC, Dickenson RA, Wu F, Andrea SB. Comparison of five assays for detection of Clostridium difficile toxin. J. Mol. Diagnostics13(4), 395–500 (2011).
  • Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol.47(10), 3211–3217 (2009).
  • Peterson L, Mehta MS, Patel PA et al. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am. J. Clin. Pathol.136(3), 372–380 (2011).
  • Peterson L, Robicsek A. Does my patient have Clostridium difficile infection? Ann. Inter. Med.151(3), 176–179 (2009).
  • Larson A, Fung A, Fang F. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J. Clin. Microbiol.48(1), 124–130 (2010).
  • Novak-Weekley S, Marlowe E, Miller J et al.Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J. Clin. Microbiol.48(3), 889–893 (2010).
  • Tenover F, Novak-Weekley S, Woods C et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol.48(10), 3719–3724 (2010).
  • Sharp S, Ruden L, Pohl J, Hatcher P, Jayne L, Ivie W. Evaluation of the C. Diff Quik Chek complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol.48(6), 2082–2086. (2010).
  • Wilcox M, Planche T, Fang F, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J. Clin. Microbiol.48(12), 4347–4353 (2010).
  • Alcala L, Sanchez-Cambronero L, Catalan M et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J. Clin. Microbiol.46(11), 3833–3835 (2008).

Website

  • American Society for Microbiology. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile. www.asm.org

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.